Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
University of Malaya
Kuala Lumpur, MalasiaPublicaciones en colaboración con investigadores/as de University of Malaya (3)
2024
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816
2022
-
Global multi-stakeholder endorsement of the MAFLD definition
The Lancet Gastroenterology and Hepatology
2019
-
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
Nature Communications, Vol. 10, Núm. 1